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Abstract
OBJECTIVES: Surgery for vascular anomalies can occasionally fail to relieve symptoms, especially when severe tracheobronchial malacia
persists. We studied outcomes in children who underwent airway stenting for severe post-surgical airway malacia and tested known clin-
ical and surgical prognostic factors.
METHODS: Among 257 children evaluated for tracheobronchial vascular compression, we reviewed the clinical charts for the 59 patients
(23%) who underwent surgery. After surgery, children in whom severe malacia and respiratory symptoms persisted underwent airway
stenting.
RESULTS: Among the 59 patients (boys: 58.1%, median age: 6.4 months, age range: 0.1–182.8 months), 79.7% had major comorbidities,
39% additional upper airway anomalies and 15.2% abnormal bronchial anatomy. Diagnostic imaging identified seven vascular anomalies:
innominate artery compression 27.1%, left bronchial compression from the descending aorta and left pulmonary artery 20.3%, lesions
associated with right aortic arch 22.0%, double aortic arch 13.6%, bovine arch type 10.2%, aberrant right subclavian artery 5.1% and
pulmonary artery sling 1.7%. For severe residual malacia and severe persistent respiratory symptoms, 20 patients (33.9%) had silicone or
metallic stents inserted. The most frequent indication for stenting was double aortic arch (P = 0.02 by chi-square test). A clinical prognostic
factor for permanent stenting was left bronchial compression from the descending aorta and left pulmonary artery [odds ratio (OR):
14.667, 95% confidence interval (CI): 2.881–74.659], particularly if associated with congenital heart disease (OR: 30.00, 95% CI: 4.349–
206.927). All silicone stents but one were successfully removed; metallic uncovered stents were patent and completely re-epithelialized.
CONCLUSIONS: When surgery leaves severe airway obstruction and respiratory symptoms unchanged, children with tracheobronchial
malacia can safely undergo airway stenting.
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INTRODUCTION
Vascular airway compression needing surgical correction is an es-
pecially challenging problem in infants and young children.
Because the thoracic vasculature lies close to and supplies the
trachea and bronchi, eventual anatomical variations especially in
children can compress the airway, cause malacia and reduce the
airway lumen. Although about 3% of the childhood population
has vascular anomalies, these lesions rarely cause symptomatic
compression, requiring a surgical approach. Despite successful
surgical airway decompression residual tracheobronchial mala-
cia, whose causes remain unclear[1, 2], can severely complicate
the child’s postoperative course by delaying recovery [3], hinder-
ing extubation [4], increasing the need for asthma medications [1]
and sometimes requiring repeated hospitalization for severe per-
sistent respiratory symptoms [5].
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Whether and if so how to treat children with residual tracheo-
bronchial malacia and severe respiratory symptoms remains con-
troversial. The currently preferred options include prolonged
intubation or tracheostomy [6]. Surgical options include various
procedures [7], such as slide tracheoplasty [8, 9] whenever the
child’s clinical conditions allow. More recently proposed thera-
peutic techniques are external tracheobronchial suspension
within a ring-reinforced polytetrafluoroethylene prosthesis [10],
anterior tracheal suspension [11] and airway stenting [12].
Although tracheobronchial stents are an attractive conservative
option for restoring lumen patency in adults their use in children
remains debatable given that the child’s constantly growing body
makes it difficult to predict the device’s outcome in the airway
[13]. Most paediatric series therefore consider stenting proced-
ures as the last option for critically ill children [14, 15]. Having re-
liable evidence-based information from a centre specialized in
interventional airway endoscopy would possibly help thoracic
surgeons, paediatric surgeons, airway endoscopists and others
who are less experienced in managing these rare post-surgical
airway diseases in children.
This retrospective single-centre study conducted in our large-
volume tertiary referral centre was designed to find out whether
airway stenting could effectively and safely manage post-surgical
persistent severe malacia manifesting with severe respiratory
symptoms, in a series of children with tracheobronchial vascular
compression. To do so we assessed the indications for stenting
and complications during a long-term endoscopic follow-up (up
to 8 years). As our secondary objective, we used chi-square test
to evaluate whether five known baseline factors (type and sever-
ity of vascular anomalies, presence and type of comorbidities,
age, sex and surgical variables) have prognostic value for severe
persisting malacia requiring stenting.
MATERIALS AND METHODS
From a consecutive series of 257 young children with tracheo-
bronchial vascular compression seen from 2006 to 2014 at the
Respiratory Endoscopy Unit, A. Meyer Children’s Hospital
(Florence, Italy), we reviewed the clinical records for the 59 (23%)
who underwent surgical correction. The diagnosis of vascular
compression was clinically suspected and confirmed by flexible
(Karl StorzV
R
, Germany; Ø 2.5/3.7/5.2 mm) or rigid (Karl StorzV
R
,
Germany; Ø 3.0/3.5/4/4.5/5/5.5 mm) bronchoscopy and by chest
computed tomographic angiography (CTA). The diagnostic work-
up to rule out coexisting cardiac anomalies included echocardiog-
raphy. We defined severe respiratory symptoms as dependence
on ventilation, increased work of breathing or recurrent infections
that required frequent prolonged hospitalizations. Surgical plan-
ning envisaged a customized approach (with or without cardio-
pulmonary bypass) for each patient according to the specific type
of vascular anomalies (Supplementary Table S1.). After surgery,
before and immediately after chest closure, the tracheal or bron-
chial lumen was visualized with a rigid bronchoscope.
According to the residual tracheal or bronchial obstruction
and whether symptoms persisted after surgical correction, to as-
sess the indications for stenting, patients were divided into three
groups. Children with mildly reduced (<50%) or moderately
reduced lumen (50–70%) and symptom improvement underwent
clinical and endoscopic follow-up. Children with moderately
reduced lumen (50–70%) and severe persistent respiratory symp-
toms but no vascular collision and in whom CTA confirmed
sufficient space between the airway and the previously dissoci-
ated vessel, underwent airway stenting. Symptomatic patients
with permanent vascular collision were scheduled for further sur-
gical correction. Children who had severely reduced lumen









) were preferred for children with tracheo-
malacia and stainless steel metallic stents (Jostent, AbbottV
R
) for
those with bronchomalacia. Stents were placed in the operating
theatre using a rigid bronchoscope with patients under general
anaesthesia (sevoflurane inhalation ± intravenous propofol) and
radiological guidance, as previously described [16].
Children who had silicone and covered Nitinol stents—inserted
as non-permanent devices for subsequent removal—underwent
bronchoscopic follow-up every 2, 4 or 6 months depending on
whether granulation tissue tended to develop. To minimize the
risk of granulation, all patients received inhaled corticosteroids. If
granulation tissue formed causing airway obstruction, it was
removed by laser. During follow-up, if rigid bronchoscopy showed
that the stent was smaller in diameter than the trachea, the stent
was removed and airway patency re-evaluated. If malacia re-
mained unchanged a larger-diameter stent was inserted to allow
for airway growth. If malacia improved the endoscopist attempted
to remove the stent and the patient continued clinical follow-up.
Children who had stainless steel metallic stents—inserted and
intended to remain as permanent devices—underwent broncho-
scopic follow-up every 4–6 months up to 1 year and then at pre-
fixed times to calibrate stent diameter finally according to airway
growth.
Technical success was defined as effective stent insertion in the
appropriate site in a single bronchoscopic session. Clinical suc-
cess was considered as clinical improvement when the child was
weaned off mechanical ventilation or respiratory symptoms dra-
matically improved or respiratory infections diminished after the
procedure.
Statistical analysis
To seek possible prognostic factors related to persisting malacia
requiring permanent stenting we used Pearson’s chi-square test
with odds ratios (OR) and 95% confidence intervals (CI) to test
known baseline clinical and surgical variables including the type
of vascular anomalies and presence and type of comorbidities
[1]. Continuous variables are reported as means ± standard devi-
ation (SD) or median and range. P values equal to or more than
0.05 were considered to indicate statistical significance, all tests
were two-tailed. Data were analysed using the SPSS system (ver-
sion 22.0; SPSS Inc., Chicago, Illinois, USA).
The study was approved by the research and institutional re-
view board at Meyer Children Hospital, Florence, Italy (146/2014).
RESULTS
The hospital records for the 257 children showed that 59 con-
secutive children (boys: 58.1%, median age: 6.4 months, range:
0.1–182.8 months) underwent surgery to remove airway com-
pression. In these 59 children, diagnostic imaging including
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bronchoscopy distinguished seven vascular anomalies: innomin-
ate artery compression in 16 patients (27.1%), left bronchial com-
pression from descending aorta and left pulmonary artery in 12
(20.3%), lesions associated with right aortic arch in 13 (22.0%),
double aortic arch in 8 (13.6%), bovine arch type in 6 (10.2%), ab-
errant right sub-clavian artery in 3 (5.1%) and pulmonary artery
sling in 1 (1.7%). Of the 59 children, 47 (79.7%) had major comor-
bidities (24 had oesophageal atresia with tracheoesophageal fis-
tula; 18 congenital heart disease; 2 congenital lobar emphysema;
1 tracheal hypoplasia; 1 visceral angiomatosis and 1 Rubinstein
Taybi syndrome). In addition, 23 (39%) patients had airway
anomalies: 8 vocal cord anomalies, 7 sub-glottic stenosis, 5 choa-
nal atresia, 1 laryngotracheal cleft, 1 global laryngomalacia, 1 la-
ryngeal web and 9 (15.2%) bronchial anomalies. The reports for
52 (88.1%) patients mentioned previous surgical treatments for
various reasons: 20 congenital heart disease (Supplementary
Table S2), 23 oesophageal atresia or tracheoesophageal fistula,
surgical corrections, 2 choanal dilation, 2 vocal cordotomy, 6 lar-
yngotracheoplasty, 2 supraglottoplasty, 3 laryngotracheal cleft re-
pair, 1 lobectomy and 9 Nissen fundoplication.
Surgery in 32 of the 59 children (54.2%) achieved mild lumen
reduction with clinical improvement, in 12 (20.4%) residual mod-
erate lumen reduction (5 asymptomatic and 7 symptomatic) and
in 15 (25.4%) persistent severe lumen reduction (Supplementary
Table S3). The 37 children in whom respiratory symptoms and
luminal loss improved after surgery (32 with mild lumen reduc-
tion + 5 with moderate lumen reduction without symptoms)
underwent a clinical follow-up.
Of the seven children with persistent moderate lumen reduc-
tion and severe respiratory symptoms four underwent aortopexy.
Among them, despite undergoing the second operation, one of
the patients required a metallic stent inserted into the left bron-
chus and one an hourglass-shaped silicon stent placed for 2
months in the trachea (Tables 1 and 2).
Of the remaining 18 children who underwent airway stenting,
in 3 children stenting was indicated for persistent moderate
lumen reductions and severe respiratory symptoms and in 15 for
persistent severe lumen reduction.
In all 20 children who required stenting we obtained technical
and clinical success immediately after tracheobronchial stenting.
After stenting, all the six children were successfully weaned off
mechanical ventilation and are in spontaneous breathing. The
three patients who underwent tracheotomy were extubated.
Overall, 2 covered Nitinol and 26 silicone stents were placed
in the trachea in 12 children and 10 ballon expandable metallic
stents (Jostent, AbbottV
R
) in the left mainstem bronchus in 8 pa-
tients. Of the 26 silicone stents used, 12 were cylinder-shaped (n:
5 Poliflex, and n: 7 DumonV
R
), 10 hourglass-shaped (DumonV
R
)
and 4 Y-shaped (DumonV
R
).
In one patient with pulmonary sling and tracheal stenosis (Table
1, Patient 12), as the preferred surgical approach we corrected the
sling and repositioned it close to the main pulmonary artery and
simultaneously undertook a tracheoplasty. Tracheoplasty involved
reconstructing a pericardial patch with cartilage strips. In our pa-
tient, the pericardium used for enlargement collapsed during extu-
bation and we had to insert a tracheal stent.
The 11 patients whose silicone stents were removed after a
median 4.5 months (0.5–24 months) completed follow-up after a
median 2.9 years (range 0.5–7.7 years), except for two children
who were lost to follow-up after 0.1 and 4.4 years. Patients with
a stent still in place (1 silicon and 8 metallic stents) were followed
for a median 5.3 years (range 3.2–8.1 years).
Among minor silicone stent-related complications, granula-
tions (removed by laser) were found in 8/21 Dumon (38.1%) and
3/5 (60%) Poliflex stents. The only major silicone stent-related
complication was a tracheal dislocation in one child. When the
device was removed 6 months later, chest CTA and bronchos-
copy showed new previously non-existing pulsatile compression
by the pulmonary artery and descending aorta (Tables 1 and 2,
Patient 4). The child underwent a second posterior aortopexy
and a Y-stent (DumonV
R
) was inserted to treat the residual severe
tracheal and left bronchial malacia.
Balloon expandable metallic stents required a mean (SD) 4.5
(3.7) calibrations or dilatations, are still in place in all eight chil-
dren at a mean (SD) 4.9 (2.3) year-follow-up and are completely
re-epithelialized. Ovalizations requiring dilations were found in
6/10 (60%) children with Jomed stents. One child with left bron-
chial compression from the descending aorta and the left pul-
monary artery underwent a posterior aortopexy 26 months later
to correct continuous stent ovalization related to the persistent
compression by the descending aorta. Granulations (removed by
laser) were found in the two children with Nitinol stents. None of
the children who had metallic stenting experienced bronchial
stenosis.
Data for the endoscopic follow-up showed that the 19 children
who had an airway stent placed after surgery had corrected vas-
cular compression are all alive and their respiratory symptoms
have improved. Only one patient died of complications related
to her visceral angiomatosis but stent placement reduced her re-
spiratory symptoms (Tables 1 and 2).
When we analysed outcomes according to the type of vascular
compression, 75% of children with double aortic arch, 50% with
left bronchial compression from the descending aorta and the
left pulmonary artery, 30.8% with right aortic arch anomalies,
16.7% with bovine arch type, 12.5% with innominate artery com-
pression and the child with pulmonary artery sling required sili-
con or metallic stents (P = 0.02 by chi-square test). In 50% of
children with left bronchial compression from the descending
aorta and left pulmonary artery, 15.4% with right aortic arch
anomalies and 6.3% with innominate artery compression, a stent
is still in place (P = 0.017). Data for comorbidities showed that
more children with than without coexisting congenital cardiac
disease still have a stent in place (35.3% vs 7.1%; P = 0.013 by chi-
square test).
In answer to our secondary objective, among vascular anoma-
lies, chi-square test identified as a prognostic factor for persistent
severe malacia requiring permanent stenting the presence of left
bronchial compression from the descending aorta and left pul-
monary artery (OR: 14.667, 95% CI: 2.881–74.659), particularly
when combined with coexisting congenital heart disease (OR:
30.00, 95% CI: 4.349–206.927). No relationships were found be-
tween the other clinical and surgical variables tested including
age, other major comorbidities and previous surgical treatment
and airway stenting.
DISCUSSION
Our new findings in this retrospective study from a single referral
centre specialized in interventional airway endoscopy suggest
that airway stenting can successfully manage post-surgical per-
sistent severe malacia in children with tracheobronchial vascular
compression and severe respiratory symptoms. Our endoscopists
do about 1200 airway procedures per year (about 200 new
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patients) often for children with severe airway malformations and
comorbidities. Our study therefore provides previously unavail-
able evidence-based information from a large case series on
these rare vascular anomalies. Although the considerable differ-
ences in age and co-morbidities make our findings hard to inter-
pret they closely reflect this heterogeneous childhood
population. Among the 59 children with vascular anomalies who
underwent surgery to treat severe respiratory symptoms, one-
third required stent placement for residual severe tracheobron-
chial malacia and unchanged severe respiratory symptoms. Few
children who underwent vascular surgery (15.2%) in this series
still have a stent in place. After a long follow-up (up to 8 years),
endoscopy documented a dislocated or ovalized stent, each
complication in one child. The vascular lesion associated with the
highest risk of leaving a stent in place was left bronchial com-
pression from the descending aorta and left pulmonary artery,
particularly if combined with congenital heart disease.
No information yet explains why post-surgical persistent malacia
arises. In our series, none of the reported potential causes of re-
sidual tracheobronchial malacia such as severity and duration of
extrinsic compression and age at the time of surgical correction [1],
were significantly associated with malacia. In 37% of the children
who had their vascular anomalies surgically corrected in our series,
the diagnostic work-up described severe malacia and severe per-
sistent respiratory symptoms. Long-term follow-up studies after
surgery for vascular compression report different degrees of airway
obstruction, in variable rates ranging from 9 to 14% of children [17,
18]. In their retrospective study, Humphrey et al., [1] reported
chronic postoperative symptoms in 80% of patients who had the
vascular compression before 6 months of age. Tracheobronchial
malacia might persist when an insult damages the developing car-
tilage at a critical moment thus precluding future recovery [2].
When we assessed how we managed residual malacia and severe
respiratory symptoms in the 59 children who underwent surgery
for vascular collision, we found that one-third had a permanent or
non-permanent airway stent placed. Growing evidence suggests
airway stenting as a conservative treatment in children [19] to allow
earlier extubation and relieve compressive symptoms [4, 20].
Nicolai [14] indicated this treatment only in extremely severe cases
(long-lasting failure to wean from ventilation due to airway obstruc-
tion or ‘dying spell’ on ventilation due to dynamic over inflation).
Our experience in treating these children suggests these major
questions to ask before undertaking stenting: Does the patient have
residual obstruction that surgery left unchanged? Does residual ob-
struction affect respiratory status or prolong the need for ventila-
tion? and Which kind of stent should be used?
When we assessed the indications for stenting, a finding that
seemingly justifies tracheobronchial stenting is that surgery for
vascular airway compression left the severity of the preoperative
endoscopic findings unchanged (>70% lumen reduction). In our
series, patients with critical residual malacia underwent stenting
soon after surgery. Although this timely choice might seem un-
necessarily invasive, Vinograd et al., [21] have already tried a
prompt approach treating patients under the same anaesthesia
with a prosthetic airway splinting procedure when aortic suspen-
sion failed to prevent tracheal collapse. Similarly, others in the
Table 1: Demographic characteristics, coexisting diseases and type of vascular compression in children who required stent place-
ment in trachea or in left mainstem bronchus
Pt Age (y) Sex Coexisting diseases Vascular compression
1a 0.2 Boy — Double aortic arch
2a 0.5 Boy Congenital heart disease Innominate artery compression
3a 0.1 Girl — Double aortic arch
4a 6.0 Girl Tracheoesophageal fistula Compression from descending
aorta and left pulmonary artery
5a 1.6 Girl — Right aortic arch + ALSA
6a 0.4 Boy Tracheoesophageal fistula Bovine arch type
7a 0.3 Boy — Double aortic arch
8a 0.6 Boy — Double aortic arch
9a 0.1 Girl Congenital heart disease Double aortic arch
10a 2.4 Boy Tracheoesophageal fistula Innominate artery compression
11a 0.1 Boy — Double aortic arch
12a 1.4 Boy Tracheal hypoplasia Pulmonary sling
13b 0.9 Girl Tracheoesophageal
fistula + laryngotracheal cleft
Innominate artery compression
14b 0.5 Girl Congenital heart disease Compression from descending
aorta and left pulmonary artery
15b 0.7 Boy Laryngotracheal cleft Right aortic arch + ALSA
16b 0.3 Girl Congenital heart disease Compression from descending
aorta and left pulmonary artery
17b 0.1 Boy Congenital heart disease Compression from descending
aorta and left pulmonary artery
18b 0.6 Boy Congenital heart disease Compression from descending aorta
and left pulmonary artery
19b 0.4 Girl Congenital heart disease Right aortic arch + ALSA
20b 7.0 Girl Congenital heart disease Compression from descending aorta
and left pulmonary artery
ALSA: anomalous left subclavian artery.
aStent placement in trachea.
bStent placement in left mainstem bronchus.
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same operative setting treated severe residual tracheobronchial
malacia within a ring-reinforced polytetrafluoroethylene prosthe-
sis and anterior tracheal suspension [10, 11]. We used tracheo-
plasty to treat severe malacia after surgery for pulmonary sling in
one child, as already described [22]. Even though stenting can be
a hazardous undertaking if done by inexperienced staff, a centre
with wide expertise in using these devices can undertake the pro-
cedure easily and safely [16].
The indication for stenting in patients with moderate residual
airway malacia and persistent respiratory symptoms are less
clear. In our patients, when surgery failed to resolve the initial
symptoms, stenting dramatically and rapidly improved their re-
spiratory status and restored spontaneous breathing. Others have
already successfully used tracheal stents in patients with
persistent and severe tracheomalacia to allow earlier extubation
after surgery and relieve compressive symptoms [15, 23].
An equally important choice in planning stenting is the type of
stent to use. Metallic balloon expandable stents are a major cause
for concern given that once inserted they must be considered as a
permanent device [12, 14]. Despite concern, they have great ad-
vantages. Apart from ensuring accurate placement and precise lu-
minal diameter, they leave mucous clearance unchanged and
rarely migrate [12, 14, 16, 19]. Several reports describe severe com-
plications such as excessive granulation tissue formation, arterio-
bronchial fistulas, airway perforation or bronchial stenosis [13, 15,
21]. In our series, with a long-term follow-up, all the metallic un-
covered stents are still in place, completely re-epithelialized and
have led to few minor complications and persistent ovalization in
Table 2: Indications for stenting, stent characteristics and follow-up for children who required stent placement
Pt Indication for stenting Stent type Stent removal (months) Outcome Follow-up
(years)
1a >70% lumen reduction D 7 57 2 Resolution Completed (0.5)
2a Ventilator-dependent D 7 20 1 Weaned Completed (6.1)
D 7 57 Decannulated
3a Ventilator-dependent D 7 30 1.2 Weaned Completed (7.7)
D 10 30





5a >70% lumen reduction D 9 30 12 Resolution Completed (1.2)
D 11 30
D 12 1012
6a >70% lumen reduction P 8 20 4.5 Resolution Completed (2.1)
P 8 30
7a >70% lumen reduction P 8 20 4.5 Resolution Completed (4.5)
P 10 30
P 12 20
8a >70% lumen reduction D 8 68 4 Resolution Lost
(4.4)
9a >70% lumen reduction D 7 20 0.5 Weaned Lost
D 7 57 (0.1)
10a >70% lumen reduction D 11 911 1 Resolution Completed (1.2)
D 12 1012
11a >70% lumen reduction D 6 20 5 Weaned Completed (2.9)
D 8 68
Anterior aortopexy




13b Persistent symptoms Posterior aortopexy Patent Decannulated (4.6)
J 17-6/12
14b >70% lumen reduction J 12-6/12 Patent Resolution (5.5)
15b >70% lumen reduction J 12-6/12 Patent Decannulate Weaned (8.1)
16b >70% lumen reduction J 17-6/12 Patent Resolution (6.5)
17b >70% lumen reduction J 17-6/12 Patent Weaned (5.0)
18b >70% lumen reduction J 12-6/12 Patent Resolution (6.2)
J 12-6/12
19b >70% lumen reduction J 12-6/12 Patent Death (0.4)
20b >70% lumen reduction J 17-6/12 Patent Resolution (3.2)
J 12-6/12
Posterior aortopexy
Outcome resolution = clinical improvement: outcome improved when the child was weaned off mechanical ventilation or respiratory symptoms dramatically
improved or respiratory infections decreased after the procedure.
D: Dumon stent; N: Nitinol stent; P: Palmaz; J: Jomed stent.
aStent placement in trachea.
bStent placement in left mainstem bronchus.
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only one child. We attribute these promising results to the fact
that rather than considering stenting as an alternative to aorto-
pexy, we reserve stent placement to patients without CTA-
documented residual vascular compression, as already described [24].
Equally important, we closely follow these children with scheduled
endoscopic evaluations, that considered the child’s growth.
For use in children with tracheomalacia to facilitate our patients’
spontaneous improvement, we preferred silicon or Nitinol-covered
stents both easily removable devices. All the children were eventu-
ally successfully weaned off mechanical ventilation, are in spontan-
eous breathing and had their tracheal stents successfully removed
after a median 4.5 months. Hence silicon stents and Nitinol-
covered stents function as non-invasive, non-permanent devices
that can temporarily overcome the child’s symptoms, are relatively
easy to place and remove and are well tolerated. A disadvantage is
that they can become obstructed by mucus and frequently migrate
[18] as happened in one child in our series. Two studies conducted
in recent years described the use of biodegradable stents also in
children with residual tracheobronchial obstruction after surgery to
remove vascular compression and showed promising results [25].
When we analysed the hospital reports to understand the
specific type of vascular compression that required stenting, we
found that the most frequent indication was double aortic arch. In
children with a double aortic arch, dividing the anterior arch some-
times fails to relieve the obstruction [26] and leaves the underlying
tracheomalacia untreated. As many as 50% of these children appear
to have residual symptoms secondary to malacia after surgical
treatment [27]. In two children in our series residual symptoms sec-
ondary to post-surgical malacia required an aortopexy, as others
have underlined [26, 27]. In six children in our series who had a
double aortic arch, tracheal stents rapidly resolved the respiratory
symptoms and the improvement persisted.
In our study, extending current reports, the prognostic factor
most closely related to persistent severe malacia requiring per-
manent stenting was left bronchial compression from the des-
cending aorta and left pulmonary artery, particularly if combined
with congenital heart disease. The high percentage of residual left
bronchial malacia after surgery in this type of vascular anomaly
accords with evidence that aortopexy can leave bronchial mala-
cia unchanged [28]. When the surgical option fails in these chil-
dren some recommend stenting [23, 29]. Managing residual
bronchial obstruction in these severely ill patients, particularly
ones with coexisting congenital heart disease can be difficult in-
sofar as children with impaired cardiovascular physiology poorly
tolerate hypoventilated or atelectatic lung segments [30].
This study has some limitations. Most patients described in this
series were in severe clinical conditions and had severe comor-
bidities and airway anomalies. Both factors could have acted as
confounding bias for the initial and post-surgical symptoms.
Another limitation is that we evaluated symptomatic improve-
ment after stenting on clinical criteria alone without lung func-
tion tests. Nor did we enrol a control group without airway
stenting to compare the clinical outcome in patients with residual
malacia or persistent respiratory symptoms or both, because for
ethical reasons we were unable to abstain from treating children
with severe respiratory symptoms and severe malacia.
CONCLUSION
When surgical correction leaves airway obstruction causing chronic
severe respiratory symptoms definitively unresolved, airway
stenting done in specialized centres provides a safe alternative op-
tion a longer follow-up would be necessary to assess the effects of
these devices in the growing child. Future research might seek fur-
ther information on risk factors for respiratory symptoms in chil-
dren who have undergone surgery to correct vascular anomalies.
SUPPLEMENTARYMATERIAL
Supplementary material is available at EJCTS online.
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